Skip to main content
IFRS Academy

CERTYNEX IFRS ACADEMY

Search the Academy

Home
My learning path
Exercises & quizzes
Cases
Workpapers
Exams
My progress

IFRS 2Workpapers (Step 4 of 5)

Workpaper template

Step 4 of 5
WorkpaperIFRS 2 — Share-based PaymentL2 · L3

Equity-settled award: cumulative expense, expense of the period, reserve and entries

5 missions10 sections to document75 min
Prepared by
AI-assisted draft
Reviewed by
Not reviewed — human review required
Status
Published

Objective of the workpaper

Record the grant-date fair value, the expected total cost at the closing date (fair value × number of instruments expected to vest), the elapsed share of the vesting period and the cumulative expense already recognised. Compute the cumulative expense at the closing date, then the expense of the period as the difference from the cumulative expense already recognised: it is negative when the revision of the expected number calls for a reversal. Reconcile the closing reserve with the ledger reserve. The total cost, the elapsed share and the numbers are case data; the grant-date fair value is never revised.

10 sections · 31 blocks · 6 calculations · 3 entries

  • IFRS 2 §15
  • IFRS 2 §19
  • IFRS 2 §21
  • IFRS 2 §21A
  • IFRS 2

Work this workpaper as a mission

Each case that uses this template opens in the mission workspace: data, analysis, calculation, entries, conclusion and review, with your progress saved.

5 instances from the cases: the calculations and entries below are run by the calculation engine.

File and entity
Options with service, performance and market conditions: cumulative expense, revision of the expected number, no remeasurement and exercise
Case tasks documented here
  • Plan Q: compute the cumulative expense at 31 December 20X6.
  • Plan Q: compute the expense of 20X6.
  • Plan Q: compute the cumulative expense at 31 December 20X7.
  • Plan Q: compute the expense or reversal of 20X7.
  • Plan R: compute the cumulative expense at 31 December 20X6.
  • Plan Q: compute the reserve at the end of 20X7 and then at the end of 20X8.
1

Facts and data

Inputs
  • Award: beneficiaries, instruments, grant date, vesting period, settlement method

    TextRequired

    OPTIONS_FOR_100_MANAGERS_GRANTED_ON_1_JANUARY_20X6_EQUITY_SETTLED_VESTING_OVER_TWO_YEARS

  • Vesting conditions and estimate of the number of instruments expected at the closing date

    Text

    SERVICE_AND_EBITDA_TARGET_90_MANAGERS_EXPECTED_TO_STAY

  • Number of instruments expected to vest (case data)

    Number

  • Unit fair value at the grant date (case data)

    Number

    6

  • Expected total cost at the closing date: fair value × expected number (case data)

    NumberRequired

    108,000

  • Elapsed share of the vesting period (%, case data)

    NumberRequired

    50 %

  • Cumulative expense already recognised at the previous closing date

    NumberRequired

    0

  • Share-based payment reserve at the opening date

    Number

    0

  • Closing reserve per the ledger

    Number

    54,000

  • Cash received on exercise (case data)

    Number

  • Reserve transferred on exercise (case data)

    Number

  • Share capital and premium recognised on exercise (case data)

    Number

2

Supporting documents

Evidence
  • Documents obtained and referenced (plan rules, grant-date valuation, leavers schedule, ledger)

    EvidenceRequired

3

Analysis of the expense of an equity-settled award

Analysis

IFRS 2 §15IFRS 2 §19IFRS 2 §21IFRS 2 §21AIFRS 2

  • Points examined: expense of the period

    ChecklistRequired

    • Fair value fixed at the grant date and not revised afterwards
    • Services recognised as they are rendered over the vesting period
    • Service and non-market performance conditions: expected number revised, cumulative catch-up at the closing date
    • Market or non-vesting condition not met: no reversal of the expense for that reason
    • Expense of the period = cumulative expense at the closing date − cumulative expense already recognised
4

Calculations

Calculations

IFRS 2 §15IFRS 2 §19

  • Cumulative expense at the closing date (expected total cost × elapsed share)

    Calculation

    54,000

    Expected total cost at the closing date: fair value × expected number (case data) ; Elapsed share of the vesting period (%, case data)

  • Expense of the period (cumulative expense − previous cumulative expense; negative in case of a reversal)

    Calculation

    54,000

    Cumulative expense at the closing date (expected total cost × elapsed share) ; − Cumulative expense already recognised at the previous closing date

  • Part of the period to recognise as an expense

    Calculation

    54,000

    Cumulative expense at the closing date (expected total cost × elapsed share) ; − Cumulative expense already recognised at the previous closing date

  • Part of the period to reverse (downward revision)

    Calculation

    0

    Cumulative expense at the closing date (expected total cost × elapsed share) ; − Cumulative expense already recognised at the previous closing date

  • Closing reserve (opening + expense of the period − transfer on exercise)

    Calculation

    54,000

    Share-based payment reserve at the opening date ; Expense of the period (cumulative expense − previous cumulative expense; negative in case of a reversal) ; − Reserve transferred on exercise (case data) ; Closing reserve per the ledger

  • Check: ledger reserve − recomputed reserve (expected: zero)

    Calculation

    0

    Share-based payment reserve at the opening date ; Expense of the period (cumulative expense − previous cumulative expense; negative in case of a reversal) ; − Reserve transferred on exercise (case data) ; Closing reserve per the ledger

5

Illustrative entries

Entries
  • Entry of the expense of the period

    Entry

    AccountDebitCredit
    Services expense54,000
    Share-based payment reserve54,000
  • Entry of the reversal after revision of the expected number

    Entry

    Debit Share-based payment reserve ← Part of the period to reverse (downward revision) ; Credit Services expense (reversal) ← Part of the period to reverse (downward revision)

  • Entry of the exercise of the options

    Entry

    Debit Cash received on exercise ← Cash received on exercise (case data) ; Debit Share-based payment reserve ← Reserve transferred on exercise (case data) ; Credit Share capital and premium ← Share capital and premium recognised on exercise (case data)

6

Judgments: vesting period and number of instruments expected

Judgment

IFRS 2 §15IFRS 2 §19IFRS 2 §21IFRS 2 §21AIFRS 2

  • Vesting period retained

    JudgmentRequired

    Vesting period confirmed

    Vesting period confirmed / Vesting period revised / Not applicable

    Professional judgment: the vesting period runs from the grant date to the date on which all the vesting conditions are met; its length is an estimate of the case when a performance condition determines it.

  • Rationale: grant date, date on which the service and performance conditions end

    Text

    GRANT_DATE_1_JANUARY_20X6_AND_VESTING_DATE_31_DECEMBER_20X7

  • Estimate of the number of instruments expected

    JudgmentRequired

    Best estimate unchanged

    Best estimate unchanged / Estimate revised upward / Estimate revised downward / Actual number known at the vesting date / Not applicable

    Professional judgment: the expected number is the best estimate of the entity at the closing date; only a service or non-market performance condition changes it.

  • Rationale: leavers observed and expected, achievement of the non-market performance condition

    Text

    NINETY_MANAGERS_EXPECTED_TO_STAY_BEST_ESTIMATE_OF_MANAGEMENT

7

Items to document for the disclosures

Disclosure

IFRS 2 §15

  • Information to prepare on the expense

    Checklist

    • Total expense of the period for equity-settled awards
    • How the grant-date fair value was determined
    • Number of instruments, vesting conditions and maximum term
8

Effect on the financial statements

FS impact
  • Effect derived from the entries

    Table

9

Conclusion

Conclusion
  • Cumulative expense, expense or reversal of the period, reserve reconciled with the ledger and judgments on the period and the expected number

    ConclusionRequired

10

Normative references

References
  • Normative references cited in this workpaper

    References

11

Checks and financial statement impact

  • Award describedPass
  • Expected total cost enteredPass
  • Elapsed share enteredPass
  • Previous cumulative expense enteredPass
  • Vesting period judged and supportedPass
  • Expected number judged and supportedPass
  • Share capital and premium = cash received + reserve transferredNot evaluated
  • Recomputed reserve = ledger reservePass
  • Expense entry balancedPass
  • Reversal entry balancedNot evaluated
  • Exercise entry balancedNot evaluated
Assets
0
Liabilities
0
Profit or loss
-54,000
OCI
0
Equity
0